CN Stock MarketDetailed Quotes
600436 Zhangzhou Pientzehuang Pharmaceutical
- 223.50
- -2.90-1.28%
Market Closed Dec 13 15:00 CST
134.84BMarket Cap43.79P/E (TTM)
226.00High222.69Low53.25KlotVolume226.00Open226.40Pre Close1.19BTurnover0.88%Turnover Ratio48.20P/E (Static)603.32MShares283.1952wk High9.62P/B134.84BFloat Cap177.2252wk Low249.04Limit Up603.32MShs Float485.95Historical High203.76Limit Down1.46%Amplitude-7.33Historical Low3.47Dividend TTM223.91Avg Price25.85KlotAsk1.55%Div YieldTTM100Lot Size15.50KlotBid
Zhangzhou Pientzehuang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 26.52%9.29B | 23.85%5.8B | 65.96%3.68B | 11.21%10.4B | 14.66%7.35B | 12.46%4.68B | 4.58%2.22B | 8.13%9.35B | 0.83%6.41B | 9.41%4.16B |
| Refunds of taxes and levies | -97.68%42.08K | -35.20%42.08K | ---- | 31.23%9.67M | -71.12%1.82M | -93.86%64.94K | -99.62%304.29 | --7.37M | 2,390.49%6.29M | 318.57%1.06M |
| Cash received relating to other operating activities | -12.06%111.84M | -11.70%76.67M | -23.26%48.75M | -96.60%164.55M | -97.18%127.18M | -98.01%86.83M | 100.74%63.53M | 2,451.58%4.84B | 2,134.62%4.51B | 2,575.81%4.36B |
| Cash inflows from operating activities | 25.83%9.41B | 23.20%5.87B | 63.47%3.73B | -25.55%10.57B | -31.58%7.47B | -44.05%4.77B | 5.99%2.28B | 60.69%14.2B | 66.63%10.92B | 114.80%8.52B |
| Goods services cash paid | 82.72%6.34B | 86.27%4.28B | 136.88%2.65B | 19.07%6.05B | 11.82%3.47B | 14.13%2.3B | -0.52%1.12B | 20.26%5.08B | 4.29%3.11B | 10.72%2.01B |
| Staff behalf paid | 4.22%380.81M | 6.80%265.3M | 20.36%147.32M | 12.61%553.7M | 13.75%365.4M | 14.40%248.4M | 35.96%122.4M | 7.28%491.7M | 13.54%321.24M | 12.04%217.13M |
| All taxes paid | -4.51%823.65M | -7.07%516.43M | -20.24%194.11M | 16.77%1.16B | 15.67%862.52M | 7.95%555.71M | 18.55%243.38M | 2.88%997.04M | 11.10%745.7M | 23.37%514.78M |
| Cash paid relating to other operating activities | 41.24%557.52M | 45.01%429.77M | 28.63%212.89M | -21.02%598.09M | -32.04%394.73M | -27.77%296.37M | -27.87%165.5M | -72.18%757.31M | -70.66%580.86M | -67.28%410.29M |
| Cash outflows from operating activities | 59.11%8.11B | 61.60%5.49B | 94.15%3.2B | 14.18%8.37B | 7.19%5.09B | 7.69%3.4B | 0.04%1.65B | -12.51%7.33B | -19.60%4.75B | -14.34%3.16B |
| Net cash flows from operating activities | -45.41%1.3B | -72.13%381.49M | -16.23%531.48M | -67.89%2.21B | -61.44%2.38B | -74.49%1.37B | 25.36%634.42M | 1,386.79%6.87B | 858.37%6.17B | 1,794.16%5.36B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | -84.36%2.88M | -82.16%1.59M | -82.07%1.59M | 17,193.92%2.25M | -87.96%18.4M | -93.30%8.9M | -93.14%8.85M |
| Cash received from returns on investments | -19.40%9.66M | -89.31%597.22K | ---- | -10.77%24.12M | 109.91%11.98M | 2.62%5.58M | -87.48%1.24M | 23.83%27.03M | -16.44%5.71M | -17.05%5.44M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 77.51%1.5M | 123.70%1.37M | 2,183.69%758.38K | -90.92%1.25M | -92.51%842.92K | -91.69%612.53K | -41.54%33.21K | 159.00%13.74M | 84.73%11.25M | 81.88%7.37M |
| Cash received relating to other investing activities | 45.49%9.1B | 51.54%8.9B | --668.76M | --6.29B | --6.26B | --5.87B | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 45.33%9.11B | 51.37%8.9B | 18,873.60%669.52M | 10,576.45%6.32B | 24,150.05%6.27B | 27,039.75%5.88B | -64.72%3.53M | -67.12%59.17M | -82.26%25.86M | -84.49%21.67M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -23.51%75.98M | -47.19%42.46M | -17.51%27.43M | -19.10%141.87M | -10.15%99.33M | -17.81%80.4M | 90.18%33.25M | 90.28%175.37M | 75.36%110.55M | 85.30%97.82M |
| Cash paid to acquire investments | 753,238.23%100M | ---- | ---- | -99.89%62.03K | -98.05%13.27K | -91.28%70.16K | -34.72%13.27K | 516.51%58.54M | 0.31%681.36K | 74.99%804.17K |
| Cash paid relating to other investing activities | -10.75%6.68B | -98.68%89.31M | --49.9M | 46.00%8.95B | 37.22%7.48B | 24.70%6.76B | ---- | --6.13B | --5.45B | --5.42B |
| Cash outflows from investing activities | -9.60%6.85B | -98.07%131.77M | 132.46%77.33M | 42.86%9.09B | 36.26%7.58B | 23.93%6.84B | 89.87%33.27M | 6,159.89%6.36B | 8,632.89%5.56B | 10,263.94%5.52B |
| Net cash flows from investing activities | 272.26%2.26B | 1,015.84%8.77B | 2,091.31%592.18M | 56.00%-2.77B | 76.32%-1.31B | 82.58%-957.69M | -295.56%-29.74M | -8,153.54%-6.3B | -6,851.83%-5.54B | -6,454.03%-5.5B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --4.9M | --4.9M | --4.9M | ---- | ---- | ---- | ---- | 37.68%21.59M | 36.76%21.44M | -25.82%11.63M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --4.9M | --4.9M | --4.9M | ---- | ---- | ---- | ---- | 37.68%21.59M | 36.76%21.44M | -25.82%11.63M |
| Cash from borrowing | 4.53%892.72M | -8.75%679.98M | 24.83%388.89M | -24.80%1.2B | -27.83%854.03M | -19.68%745.18M | -23.31%311.55M | 12.96%1.59B | 40.68%1.18B | 29.28%927.75M |
| Cash inflows from financing activities | 5.10%897.62M | -8.09%684.88M | 26.40%393.79M | -25.81%1.2B | -29.11%854.03M | -20.67%745.18M | -23.31%311.55M | 13.23%1.61B | 40.61%1.2B | 28.10%939.38M |
| Borrowing repayment | -10.20%884.89M | -21.25%637M | -26.09%284.6M | -18.22%1.14B | -14.42%985.35M | -10.56%808.92M | -16.83%385.07M | 2.98%1.4B | 32.05%1.15B | 21.04%904.43M |
| Dividend interest payment | 84.42%1.43B | 10,006.29%1.42B | 8.93%8.24M | 3.33%786.77M | 3.37%775.7M | -0.82%14.08M | 3.67%7.56M | 31.57%761.39M | 32.02%750.45M | -97.44%14.19M |
| -Including:Cash payments for dividends or profit to minority shareholders | 304.48%8.61M | 258.40%7.63M | ---- | 181.67%2.13M | --2.13M | --2.13M | ---- | -92.03%756K | ---- | ---- |
| Cash payments relating to other financing activities | 22.13%32.43M | -3.67%19.08M | -14.01%11.52M | 17.04%38.99M | 14.24%26.56M | 33.37%19.8M | 27.02%13.4M | 3.81%33.31M | 35.33%23.25M | 3.67%14.85M |
| Cash outflows from financing activities | 31.34%2.35B | 146.67%2.08B | -25.04%304.35M | -10.19%1.97B | -7.14%1.79B | -9.71%842.8M | -15.55%406.03M | 11.41%2.19B | 32.08%1.93B | -29.05%933.48M |
| Net cash flows from financing activities | -55.34%-1.45B | -1,327.99%-1.39B | 194.66%89.44M | -33.60%-769.3M | -29.60%-933.57M | -1,753.88%-97.62M | -26.74%-94.48M | -6.59%-575.82M | -19.91%-720.33M | 101.01%5.9M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 19.50%5.85M | 62.57%7.09M | 207.25%2.9M | -78.78%2.43M | -63.61%4.9M | -24.49%4.36M | -177.34%-2.71M | 347.28%11.44M | 639.54%13.45M | 320.05%5.78M |
| Net increase in cash and cash equivalents | 1,415.21%2.11B | 2,344.59%7.77B | 139.61%1.22B | -34,836.58%-1.33B | 285.88%139.49M | 363.21%317.66M | 19.97%507.5M | 189.49%3.84M | -161.17%-75.04M | 43.92%-120.69M |
| Add:Begin period cash and cash equivalents | -55.33%1.08B | -55.33%1.08B | -55.33%1.08B | 0.16%2.41B | 0.16%2.41B | 0.16%2.41B | 0.16%2.41B | -0.18%2.41B | -1.12%2.41B | -0.18%2.41B |
| End period cash equivalent | 25.07%3.19B | 224.00%8.84B | -21.44%2.29B | -55.33%1.08B | 9.36%2.55B | 19.33%2.73B | 3.12%2.92B | 0.16%2.41B | -8.80%2.33B | 4.11%2.29B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
